Next Article in Journal
Simulation of Helical-Baffle Inlet Structure Cyclone Separator
Previous Article in Journal
Separation of Bioactive Compounds from Pfaffia glomerata: Drying, Green Extraction, and Physicochemical Properties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Parameter Optimization Considering the Variations Both from Materials and Process: A Case Study of Scutellaria baicalensis Extract

1
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2
Polytechnic Institute, Zhejiang University, Hangzhou 310015, China
3
Jinhua Institute, Zhejiang University, Jinhua 321016, China
4
National Key Laboratory of Chinese Medicine Modernization, Zhejiang University, Hangzhou 310058, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Separations 2025, 12(6), 165; https://doi.org/10.3390/separations12060165
Submission received: 28 May 2025 / Revised: 13 June 2025 / Accepted: 16 June 2025 / Published: 17 June 2025
(This article belongs to the Section Purification Technology)

Abstract

The Quality by Design (QbD) concept has been widely applied to the optimization of traditional Chinese medicine production processes recently. This work focused on optimizing the critical purification process of Scutellaria baicalensis extract used in the preparation of Zhusheyong Shuanghuanglian. Considering the impact of noise parameters and changes in herbal properties, an experimental design method was employed for optimization. Multiple batches of Scutellaria baicalensis decoction were prepared in this research, and quantitative models of Scutellaria baicalensis herbal properties, critical process parameters (CPPs), and process evaluation indicators were established. The R2 of the quantitative models were all higher than 0.80. According to the model, the yield of baicalin was identified as a critical material property (CMA). The pH of first acid precipitation (X1), first temperature holding time (X2), pH of alkalization (X3), ethanol amount (X4), and end pH of ethanol washing (X5) were CPPs. Considering the difficulty in controlling the end pH of the ethanol washing, it was considered to be a noise parameter. The Monte Carlo probability-based method was used to calculate the design space, determining the range of controllable parameters, which was successfully validated through experiments. Normal operation ranges for controllable parameters are recommended as follows: X1 of 0.8–2.2, X2 of 25–35 min, X3 of 6.5–7.5, and X4 of 0.8–1.2 g/g.

Graphical Abstract

1. Introduction

Zhusheyong Shuanghuanglian is included in the 2020 edition of the Pharmacopoeia of the People’s Republic of China. It is prepared from three herbs: Scutellaria baicalensis, Lonicera japonica, and Forsythia suspensa [1]. It has the effects of clearing heat and detoxifying, as well as dispelling wind and relieving exterior symptoms; it is commonly used for coughs, fever, pneumonia, etc., and also helps to enhance the body’s immune function [2,3]. Among these, Scutellaria baicalensis (Scutellaria baicalensis Georgi) is widely used in traditional Chinese medicines, with its main active ingredients including various flavonoids such as baicalin, baicalein, and wogonoside [4,5,6]. These flavonoids have multiple pharmacological activities, including anti-tumor [7], antioxidant [8], antiviral activity [9], antibacterial [10], and immune-boosting [11].
Scutellaria baicalensis extract for Zhusheyong Shuanghuanglian is produced by processes such as water decoction, precipitation, ethanol washing, activated carbon treatment, and drying [1]. In a previous work, the preparation process of Scutellaria baicalensis extract was investigated [12] and determined that the critical processes are water decoction, acid precipitation, and ethanol washing based on mass transfer characterizations and similarity change. Additionally, it was found that controlling ethanol washing to a fixed pH value is challenging; therefore, this parameter is considered a noise parameter in the preparation process of Scutellaria baicalensis extract.
The steps for drug development are proposed in ICH Q8 (R2) [13], including identifying critical quality attributes (CQAs), determining critical process parameters (CPPs), developing design space, and continuous improvement. Before establishing the design space, it is usually necessary to build a mathematical model to describe the relationships between process inputs (material attributes and process parameters) and the CQAs of the drug [14]. The design space not only helps enhance the process’s robustness but also improves production flexibility and reduces the regulatory burden [15]. For example, Wang et al. considered the quality differences between batches of herb materials and used definitive screening design (DSD) to optimize the preparation process of ginkgo leaf extract, establishing the design space based on risk levels [16]. When establishing the design space, parameters that are costly or difficult to control can be treated as noise parameters [17], as shown by Tai et al., who treated the refrigeration temperature as a noise parameter [18].
The differences between batches of medicinal materials were considered in this work, different properties of Scutellaria baicalensis decoction were prepared for purification, and a quantitative model of critical herb material attributes (CMAs), CPPs, and process evaluation indicators were established. By controlling the controllable parameters, the sensitivity to noise parameters, specifically the change of pH at the end of the ethanol washing, was reduced, enhancing the robustness of the preparation process of Scutellaria baicalensis extract. In this research, the Monte Carlo probability-based method was used to establish the design space, which was verified through experiments.

2. Materials and Methods

2.1. Reagents and Herb Materials

Hydrochloric acid (36–38%, analytical grade) and sodium hydroxide (≥96.0%, analytical grade) were purchased from Sinopharm Chemical Reagents Co., Ltd. (Shanghai, China). Methanol (≥99.9%, chromatographic purity) and acetonitrile (≥99.9%, chromatographic purity) were both purchased from Merck (Darmstadt, Germany). Formic acid (≥99.9%, chromatographic purity) was purchased from ROE Scientific Inc. (Newark, NJ, USA). The reference substances of wogonoside (lot:201702, 98.5% purity), baicalin (lot:202122, 94.2% purity), and baicalein (lot:201808, 97.9% purity) were all provided by the National Institutes for Food and Drug Control (Beijing, China). Information about the different batches of Scutellaria baicalensis herb materials is shown in Table 1.

2.2. Experimental Methods

According to previous research [12], the critical processes of Scutellaria baicalensis extract preparation are shown in Figure 1, including water decoction, acid precipitation, dissolution, and second acid precipitation. In the dissolution process, alkali and ethanol were both added.
Preparation of the water decoction of Scutellaria baicalensis: Scutellaria baicalensis was extracted twice with water for 1 h each time. After filtration with filter paper under vacuum, the filtrates were combined.
Preparation of precipitate 1: a total of 2 mol/L of hydrochloric acid solution was added to adjust the pH to 1.0~2.0. The mixture was maintained at 80 °C for 30 min. Subsequently, it was left undisturbed for 12 h, filtered with filter paper under vacuum, and the precipitate was washed with water to remove residual acid on the surface. Finally, vacuum drying was carried out to obtain precipitate 1.
Preparation of the filtrate: eight times the volume of water was added to precipitate 1 under stirring, and the pH was adjusted to 7.0 using a 10% sodium hydroxide solution. An equal amount of ethanol was subsequently added, and under continuous stirring, the precipitate was dissolved. The solution was then filtered with filter paper under vacuum to obtain the filtrate.
Preparation of precipitate 2: the pH of the filtrate was adjusted to 2.0 with 2 mol/L hydrochloric acid solution, and the mixture was kept at 60 °C for 30 min before being allowed to stand for 12 h. It was then filtered with filter paper under vacuum, and the precipitate was washed with ethanol until its pH reached 4.0. Vacuum drying was finally applied to obtain precipitate 2.

2.2.1. Reference Solution Preparation

Appropriate amounts of the reference substances wogonoside, baicalein, and baicalin were vacuum-dried for 24 h and accurately weighed. They were then placed into volumetric flasks, dissolved by ultrasonication (LMTD15, Lumiere Tech Ltd., Beijing, China) with methanol, diluted to the mark, and shaken well to obtain single-reference solutions with mass concentrations of 0.594, 0.566, and 0.545 mg/mL, respectively. Accurate volumes of the individual reference solutions were then transferred into a common volumetric flask, diluted to the mark, and thoroughly mixed, yielding a mixed reference solution containing 0.119 mg/mL wogonoside, 0.113 mg/mL baicalein, and 0.109 mg/mL baicalin. Stepwise dilution of this mixed reference solution was performed to obtain a series of mixed reference solutions with varying concentrations. The resulting series of solutions were analyzed by high-performance liquid chromatography (Agilent 1100, Agilent Technologies Ltd., Santa Clara, CA, USA) to obtain the corresponding peak areas. A standard curve was plotted using concentration as the x-axis and peak area as the y-axis, and the regression equation of peak area versus concentration was derived.

2.2.2. Preparation of Test Solution

An appropriate mass of the sample to be analyzed was accurately weighed and transferred into a volumetric flask of suitable size. The Scutellaria baicalensis decoction was diluted to the mark with ultrapure water, while precipitate 2 was diluted with a 10% sodium hydroxide solution. The solutions were thoroughly mixed and set aside for subsequent use. The solutions were filtered through a 0.22 μm membrane filter, and the filtrate was placed into sample vials for high-performance liquid chromatography (HPLC) analysis to obtain the corresponding peak areas. The flavonoid concentration in the sample was then calculated based on the standard curve equation established previously.

2.2.3. Analytic Procedure

The contents of baicalin, wogonoside, and baicalein, the three flavonoid components in the water decoction, and precipitate 2 of Scutellaria baicalensis were detected using chromatographic conditions from the literature [12]. The limits of detection (LOD) of baicalin, wogonoside, and baicalein are 0.00536 mg/mL, 0.00113 mg/mL, and 0.000369 mg/mL, respectively. The limits of quantification (LOQ) are 0.0162 mg/mL, 0.00342 mg/mL, and 0.00112 mg/mL, respectively. Due to the high content of baicalin in the water decoction, chromatographic analysis can easily become overloaded. Therefore, when detecting the content of baicalin, the sample was diluted with a larger volume of water. The analysis was performed on a Waters XBridge Shield RP18 column (250 mm × 4.6 μm, 5 μm), which was purchased from Waters (Massachusetts, USA). The mobile phase consisted of 0.1% formic acid aqueous solution (A) and acetonitrile (B), with gradient elution as follows: 0–10 min, 10–15% B; 10–20 min, 15–20% B; 20–30 min, 20–25% B; 30–60 min, 25–45% B; 60–70 min, 45–60% B; and 70–75 min, 60–10% B. The flow rate was set to 0.8 mL/min, the detection wavelength was 274 nm, the injection volume was 10 μL, and the column temperature was maintained at 28 °C. The typical chromatogram obtained is shown in Figure 2.

2.2.4. Determination of Critical Process Evaluation Indicators

The main components of Scutellaria baicalensis are flavonoids. Currently, baicalin is the indicator component for quality control of Scutellaria baicalensis in the Chinese Pharmacopoeia. However, considering that traditional Chinese medicine integrates multiple components and targets for efficacy, three flavonoids were selected as indicator components: baicalin, wogonoside, and baicalein. In this research, the yields of the three active components and total solids were chosen as critical process evaluation indicators, namely, yield of baicalin (Y1), yield of wogonoside (Y2), yield of baicalein (Y3), and yield of total solids (Y4).

2.2.5. Research on Herb Properties

To research the impact of differences in Scutellaria baicalensis herbs, nine batches of Scutellaria baicalensis were selected for experiments. To quantitatively characterize the property differences among the nine batches, the following method of testing the properties of their decoctions was adopted. The fixed conditions for decocting the herbs were as follows: Scutellaria baicalensis herbs were decocted twice with 3 L of water, each time for 1 h, and the decoctions were combined. Then, the flavonoid contents and total solids of each decoction were measured, and the yields of flavonoids, total solids, and the purity of each flavonoid were calculated as quantitative indicators of herb properties. The formula for calculating the purity of flavonoid is shown in Equation (1).
P i = Y i Y s
The purity of the i-th flavonoid is Pi, the yield of the i-th flavonoid is Yi (mg/g), and the yield of the total solids is Ys (mg/g).

2.2.6. Experiment Design

DSD was used to investigate the quantitative relationships among the CPPs, CMAs, and critical process evaluation indicators. Compared with other response surface designs, fewer experimental runs are required for DSD when researching the same number of parameters [19]. DSD cannot avoid mixing third-order and higher-order effects, but in this work, it is enough to establish a quantitative model containing second-order and first-order terms. Because the fluctuations in herbal properties have a greater impact on the composition of decoctions compared with changes in decoction process parameters [20], optimization of the decoction process’s parameters was not conducted in this research.
After previous experiments and mechanism analysis [12], the selected CPPs are as follows: pH of first acid precipitation (X1), first temperature holding time (X2), pH of alkalization (X3), ethanol amount (X4), and end pH of ethanol washing (X5). The ranges of CPPs were determined based on previous work [12]. The experimental design was carried out using Design Expert 12.0 software (Stat-Ease, Minneapolis, MN, USA), with the central points repeated five times for a total of 17 experiments. Due to the difficulties in controlling the pH values at the endpoint of the ethanol washing during the experiments, the measured values in the experiments were used. To research the impacts of herbal properties, different decoctions were used in each experiment, and the experimental conditions are listed in Table 2.

2.3. Data Processing

2.3.1. CMA Screening and Process Modeling

The quantitative model of the potential CMA, CPPs, and critical process evaluation indicators was established by Formula (2).
Y = b 0 + i = 1 n b i X c , i + i = 1 n b i i X c , i 2 + i = 1 n 1 j = i + 1 n b i j X c , i X c , j + k = 1 m c k Z c , k
The numbers of the CPPs and potential CMA are n and m, respectively; Xc,i and Xc,j are CPPs; Zc,k is the potential CMA; bi, bii, bij and ck are the partial regression coefficients for each term; and b0 is the constant term. The backward stepwise regression method was used to screen the CMA, eliminating unimportant items to simplify the model, with the threshold set at 0.10. Data analysis was performed using Design Expert (Stat-Ease Inc., version 12.0, Minneapolis, MN, USA).

2.3.2. Design Space Calculation

MATLAB (R2018b, version 9.0, The Math Works Inc., Natick, MA, USA) was used for calculations, and the process was as follows [21,22,23]: It was assumed that the experimental results under different process conditions followed a normal distribution. The mean values and standard deviations of each response variable were obtained through center point experiments, and subsequently, Monte Carlo sampling was employed to simulate the values of each response under various process conditions. Modeling was carried out using stepwise regression according to Formula (2), with the models established from the Monte Carlo-simulated values used to compute predictive outcomes. Based on these model predictions, the probability of meeting all critical-process evaluation criteria was calculated. A minimum acceptable probability of 0.80 within the design space was set, with 500 simulation runs conducted. Parameter combinations satisfying the probability requirement were then summarized, followed by further statistical analysis of the controllable parameter combinations that met the probability criterion under variations in noise parameters, from which the design space was determined.

3. Results

3.1. Properties of Decoction

In this work, nine batches of Scutellaria baicalensis herbs were selected, which were decocted as described in Section 2.2.5. The flavonoid contents and total solids of each batch of decoction were measured, as shown in Table 3. The total solids yield of each batch of the decoction ranged from 380 mg/g to 492 mg/g, indicating that the amount of solids transferred from per gram of herb varied among the different batches of Scutellaria baicalensis herbs. Among the three flavonoids, baicalin had the highest yield, reaching nearly 100 mg/g herb, making it one of the main components in Scutellaria baicalensis decoction. Wogonoside followed with the second-highest yield, while baicalein had a yield below 3 mg/g herb.

3.2. Potential CMAs Identified

The Pearson correlation analysis was conducted on the properties of different batches of the decoctions to preliminarily screen the attributes of the Scutellaria baicalensis herbs. The results are shown in Table 4. The correlation coefficients between the purity of baicalin (Z5) and the yield of baicalin (Z1) or the purity of wogonoside (Z6) were all above 0.90. Therefore, the yield of baicalin (Z1) can be used as an alternative to the purity of baicalin (Z5) and the purity of wogonoside (Z6) can be used as one of potential critical attributes of Scutellaria baicalensis herbs. The correlation coefficient between the purity of baicalein (Z7) and the yield of baicalein (Z3) was above 0.95, indicating a strong correlation. Thus, the yield of baicalein (Z3) can be selected as a representative. Other potential CMAs include the yield of wogonoside (Z2) and total solids (Z4).

3.3. Influences of CMAs and CPPs

The results obtained from the DSD experiments are shown in Table 5. The yield of total solids was 2.8~49.33 mg/g. The yield of baicalin was mostly higher than 15 mg/g, and the yield of wogonoside was mostly higher than 0.1 mg/g.
Quantitative mathematical models were established for each critical process evaluation indicator, with the potential CMAs and CPPs based on Formula (2). The regression coefficients and variance analysis results of each model are shown in Table 6. All p values were less than 0.05, indicating that the models were significant. The R2 values for all models were greater than 0.80, with a small difference from R a d j 2 , suggesting that these models can explain most variations and fit well. According to the model term screening results, Z1 was the CMA, while X1, X2, X3, X4, and X5 were all CPPs.
Figure 3, Figure 4, Figure 5 and Figure 6 show the contour plots of the effects of the CMA and CPPs on each critical-process evaluation indicator. The higher was X5, and the lower were Y1, Y3, and Y4. The CMA had little effect on the other three critical process evaluation indicators except baicalein yield.

3.4. Design Space Calculation and Verification

The lower limits and minimum probability of reaching the criteria for each critical process evaluation indicator are shown in Table 7. The design space obtained by the probability-based method, and verification points are shown in Figure 7.
To conduct validation experiments, two batches of new decoctions were prepared, and their CMAs were measured. The validation experiment conditions are listed in Figure 7c,d, with the results shown in Table 8. Most of the measured values from the validation experiments closely matched the predicted values, indicating the relatively good predictive performance of the model. However, there were still some validation experiments in which the measured values of Y1, Y3, and Y4 differed significantly from the predicted values; this may be due to too few batches or unknown interference factors during modeling. The experimental results obtained at points within the design space met the set standards, suggesting that the constructed design space is relatively reliable.

4. Conclusions

In this research, the critical processes of Scutellaria baicalensis extract preparation were optimized through design space methods based on the QbD concept. First, wogonoside yield, baicalin yield, baicalein yield, and total solids yield were selected as critical process evaluation indicators. Then, DSD experiments were performed to obtain data. After that, quantitative models were established using stepwise regression for the CMAs, CPPs, and critical process evaluation indicators. The model’s R2 was above 0.80, indicating that it can explain most variations of the data. According to the model, the yield of baicalin in the decoction was screened as the CMA, while the pH of first acid precipitation, the first temperature holding time, the pH of alkalization, the ethanol amount, and the end pH of ethanol washing were CPPs. The end pH of ethanol washing was regarded as a noise parameter. The Monte Carlo algorithm was used to calculate the design space of the controllable parameters within the process, which was then validated. The validation results indicate that operating within the design space can ensure that critical process evaluation indicators such as baicalin yield meet the standards and that the quality of the extracted product retains good batch-to-batch consistency. Normal operation ranges to attain the criteria of process evaluation indicators with a probability more than 80% are recommended as follows: X1 of 0.8–2.2, X2 of 25–35 min, X3 of 6.5–7.5, and X4 of 0.8–1.2 g/g.
In this work, there are still some shortcomings. Only nine batches of Scutellaria baicalensis were investigated, and the coverage of the differences in the sources and batches of herbal materials was limited. Therefore, in industrial production, it will be necessary to collect more data. If the sample size of the herbal materials is increased, the mathematical models and corresponding design spaces need to be further updated. Additionally, although this work selected three indicator components, there was no clear correlation between the standards and the therapeutic efficacy of the components. Correspondingly, the association between the CMAs of medicinal herbs and drug efficacy has not been established. This requires more pharmacological research and clinical data support.

Author Contributions

X.Z. and Z.T., data curation and writing—original draft; X.Z., B.C. and Z.T., writing—review and editing; X.G., supervision, writing—review and editing; X.Z. and Z.T., methodology and writing; X.Z., data acquisition; X.G., conceptualization, methodology, formal analysis, funding acquisition, and supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Key Research and Development Program of China (2024YFC3506901).

Data Availability Statement

Data are available upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
QbDQuality by Design
CPPcritical process parameter
CMAcritical material attribute
CQAcritical quality attribute
LODlimits of detection
LOQlimits of quantification
DSDDefinitive Screening Design
HPLChigh-performance liquid chromatography

References

  1. State Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China; State Pharmacopoeia Commission: Ghaziabad, India, 2020. [Google Scholar]
  2. Zhang, H.; Chen, Q.; Zhou, W.; Gao, S.; Lin, H.; Ye, S.; Xu, Y.; Cai, J. Chinese medicine Injection Shuanghuanglian for treatment of acute upper respiratory tract infection: A systematic review of randomized controlled trials. Evid. Based Complement. Alternat Med. 2013, 2013, 987326. [Google Scholar] [CrossRef] [PubMed]
  3. Chen, X.; Howard, O.M.Z.; Yang, X.; Wang, L.; Oppenheim, J.J.; Krakauer, T. Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci. 2002, 70, 2897–2913. [Google Scholar] [CrossRef] [PubMed]
  4. Guo, F.Y.; Li, C.H.; Dou, J.X.; Liang, J.; Chen, Z.Q.; Xu, Z.S.; Wang, T. Research progress on pharmacological properties and application of probiotics in the fermentation of Scutellaria baicalensis Georgi. Front. Nutr. 2024, 11, 1407182. [Google Scholar] [CrossRef] [PubMed]
  5. Wen, Y.Q.; Wang, Y.Z.; Zhao, C.X.; Zhao, B.Y.; Wang, J.G. Baicalin: An active natural product with potential medicinal values. J. Asian Nat. Prod. Res. 2025, 1–25. [Google Scholar] [CrossRef] [PubMed]
  6. Zhou, X.; Liang, H.; Lu, X.; Cai, S.; Wang, B.; Zhao, Y. Flavonoids from Scutellaria baicalensis and their bioactivities. J. Peking Univ. Health Sci. 2009, 41, 578–584. [Google Scholar] [CrossRef]
  7. Cai, J.Y.; Hu, Q.C.; He, Z.L.; Chen, X.Y.; Wang, J.; Yin, X.; Ma, X.; Zeng, J.H. Scutellaria baicalensis Georgi and their natural flavonoid compounds in the treatment of ovarian cancer: A review. Molecules 2023, 28, 5082. [Google Scholar] [CrossRef] [PubMed]
  8. Lim, J.; Kim, K.; Kwon, D.; Kim, J.K.; Sathasivam, R.; Park, S.U. Effects of different solvents on the extraction of phenolic and flavonoid compounds, and antioxidant activities, in Scutellaria baicalensis hairy roots. Horticulturae 2024, 10, 160. [Google Scholar] [CrossRef]
  9. Pei, T.L.; Yan, M.X.; Huang, Y.B.; Wei, Y.K.; Martin, C.; Zhao, Q. Specific flavonoids and their biosynthetic pathway in Scutellaria baicalensis. Front. Plant Sci. 2022, 13, 866282. [Google Scholar] [CrossRef] [PubMed]
  10. Miao, N.; Yun, C.; Han, S.L.; Shi, Y.T.; Gao, Y.; Wu, S.; Zhao, Z.W.; Wang, H.M.; Wang, W.J. Postharvest UV-A radiation affects flavonoid content, composition, and bioactivity of Scutellaria baicalensis root. Postharvest Biol. Technol. 2022, 189, 111933. [Google Scholar] [CrossRef]
  11. Vrabec, R.; Vokurková, D.; Tumová, L.; Cheel, J. Ex-vivo immune-stimulating activity of Scutellaria baicalensis and its major flavonoids on human immune cells. Rec. Nat. Prod. 2022, 16, 188–193. [Google Scholar] [CrossRef]
  12. Zhang, X.; Meng, Q.; Guan, J.; Wang, Y.; Gong, X. Identification of critical sections in the preparation of Scutellaria baicalensis extract. Cent. South Pharm. 2023, 21, 123–129. [Google Scholar]
  13. ICH Guidelines. ICH Q8 (R2) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available online: https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf (accessed on 20 May 2025).
  14. Gong, X.C.; Chen, T.; Qu, H.B. Research advances in secondary development of Chinese patent medicines based on quality by design concept. China J. Chin. Mater. Medica 2017, 42, 1031–1036. [Google Scholar] [CrossRef]
  15. Watson, T.; Nosal, R.; Lepore, J.; Montgomery, F. Misunderstanding design space: A robust drug product control strategy is the key to quality assurance. J. Pharm. Innov. 2018, 13, 283–285. [Google Scholar] [CrossRef]
  16. Wang, Y.; Li, J.; Yao, J.; Liu, H.; Gong, X. Research on multi-parameter optimization of the process of Ginkgo biloba leaf extract considering quality variations among raw material batches. Chin. J. Pharm. 2025, 56, 378–388+395. [Google Scholar] [CrossRef]
  17. Gong, X.C.; Li, Y.; Guo, Z.T.; Qu, H.B. Control the effects caused by noise parameter fluctuations to improve pharmaceutical process robustness: A case study of design space development for an ethanol precipitation process. Sep. Purif. Technol. 2014, 132, 126–137. [Google Scholar] [CrossRef]
  18. Tai, Y.; Qu, H.; Gong, X. Design space calculation and continuous improvement considering a noise parameter: A case study of ethanol precipitation process optimization for the Carthami Flos extract. Separations 2021, 8, 74. [Google Scholar] [CrossRef]
  19. Dyrstad, K.; Westad, F. Interpretation of high dimensional definitive screening designs assisted by bootstrapped partial least squares regression. Chemom. Intell. Lab. Syst. 2024, 253, 105218. [Google Scholar] [CrossRef]
  20. Zhong, W.; Chen, S.; Zhang, J.; Wang, Y.; Liu, A. Which one is more important, raw materials or productive technology?—A case study for quality consistency control of Gegen Qinlian decoction. China J. Chin. Mater. Medica 2016, 41, 1027–1032. [Google Scholar] [CrossRef]
  21. Pan, J. Research on the Control Strategy of Traditional Chinese Medicine Ethanol Precipitation Process Based on a Membrane Dispersion Micromixer. Master’s Thesis, Zhejiang University, Hangzhou, China, 2021. [Google Scholar]
  22. Shen, J. Study on the Quality Control Method of Critical Purification Processes of Lonicerae Japonicae Flos Extract. Master’s Thesis, Zhejiang University, Hangzhou, China, 2018. [Google Scholar]
  23. Shao, J.; Qu, H.; Gong, X. Comparison of two algorithms for development of design space-overlapping method and probability-based method. China J. Chin. Mater. Medica 2018, 43, 2074–2080. [Google Scholar] [CrossRef]
Figure 1. Extraction process of Scutellaria baicalensis products.
Figure 1. Extraction process of Scutellaria baicalensis products.
Separations 12 00165 g001
Figure 2. HPLC chromatogram of Scutellaria baicalensis extract. (a) The decoction was diluted 10 times. (b) The decoction was diluted 100 times. (c) Mixed reference solution. Peak 1 is wogonoside, Peak 2 is baicalein, and Peak 3 was baicalin.
Figure 2. HPLC chromatogram of Scutellaria baicalensis extract. (a) The decoction was diluted 10 times. (b) The decoction was diluted 100 times. (c) Mixed reference solution. Peak 1 is wogonoside, Peak 2 is baicalein, and Peak 3 was baicalin.
Separations 12 00165 g002
Figure 3. Contour plot of Y1. X1 = 1.5; X2 = 30 min; X3 = 7.0; X4 = 1.0 g/g.
Figure 3. Contour plot of Y1. X1 = 1.5; X2 = 30 min; X3 = 7.0; X4 = 1.0 g/g.
Separations 12 00165 g003
Figure 4. Contour plot of Y2. X1 = 1.5; X2 = 30 min; X3 = 7.0.
Figure 4. Contour plot of Y2. X1 = 1.5; X2 = 30 min; X3 = 7.0.
Separations 12 00165 g004
Figure 5. Contour plot of Y3. (a) X2 = 30 min; X4 = 1.0 g/g; and X5 = 4.2. (b) X1 = 1.5; X4 = 1.0 g/g; and X5 = 4.2.
Figure 5. Contour plot of Y3. (a) X2 = 30 min; X4 = 1.0 g/g; and X5 = 4.2. (b) X1 = 1.5; X4 = 1.0 g/g; and X5 = 4.2.
Separations 12 00165 g005
Figure 6. Contour plot of Y4. X1 = 1.5; X2 = 30 min; X3 = 7.0.
Figure 6. Contour plot of Y4. X1 = 1.5; X2 = 30 min; X3 = 7.0.
Separations 12 00165 g006
Figure 7. Design space diagram. (a) Z1 = 99.29 mg/g; X2 = 35 min; X5 = 4.0~4.5. (b) Z1 = 99.29 mg/g; X1 = 2.2; X5 = 4.0~4.5. (c) Z1 = 85.468 mg/g; X2 = 35 min; X3 = 6.5; X5 = 4.0~4.5. (d) Z4 = 90.127 mg/g; X2 = 30 min; X3 = 7.5; X5 = 4.0~4.5. The color bar indicates the probability of the critical process evaluation indicators reaching the criteria; ○ indicates the verification point.
Figure 7. Design space diagram. (a) Z1 = 99.29 mg/g; X2 = 35 min; X5 = 4.0~4.5. (b) Z1 = 99.29 mg/g; X1 = 2.2; X5 = 4.0~4.5. (c) Z1 = 85.468 mg/g; X2 = 35 min; X3 = 6.5; X5 = 4.0~4.5. (d) Z4 = 90.127 mg/g; X2 = 30 min; X3 = 7.5; X5 = 4.0~4.5. The color bar indicates the probability of the critical process evaluation indicators reaching the criteria; ○ indicates the verification point.
Separations 12 00165 g007
Table 1. Number of different batches of herb materials.
Table 1. Number of different batches of herb materials.
Herb Identification NumberBatch of HerbsManufacturer
S1B2008191-01Hebei Chufeng Decoction Pieces Co., Ltd. (Hebei, China)
S2210301Anhui Daoyuantang Decoction Pieces Co., Ltd. (Anhui, China)
S3168210701Hebei Linyitang Pharmaceutical Co., Ltd. (Hebei, China)
S4168200601Hebei Linyitang Pharmaceutical Co., Ltd. (Hebei, China)
S5201101Anhui Daoyuantang Decoction Pieces Co., Ltd. (Anhui, China)
S6211109Bozhou Kangyiyin Biotechnology Co., Ltd. (Bozhou, China)
S7211112Luan Danbell Biological Technology Co., Ltd. (Luan, China)
S8168211001Hebei Linyitang Pharmaceutical Co., Ltd. (Hebei, China)
S9168201702Hebei Linyitang Pharmaceutical Co., Ltd. (Hebei, China)
Table 2. DSD parameter table.
Table 2. DSD parameter table.
Experiment NumbersNumber of Herb MaterialpH of First Acid Precipitation
X1
First Temperature Holding Time (min)
X2
pH of Alkalization
X3
Ethanol Amount (g/g)
X4
End pH of Ethanol Washing
X5
1S10.8357.01.24.88
2S22.2357.50.84.35
3S31.5307.01.04.47
4S12.2306.51.24.34
5S21.5357.51.24.29
6S40.8256.51.24.75
7S51.5256.50.84.01
8S40.8307.50.84.18
9S52.2257.00.84.04
10S60.8356.50.84.10
11S70.8257.51.04.43
12S62.2356.51.03.96
13S72.2257.51.24.25
14S31.5307.01.04.19
15S31.5307.01.03.96
16S81.5307.01.04.29
17S91.5307.01.04.00
Table 3. Physicochemical properties of different batches of the Scutellaria baicalensis decoction.
Table 3. Physicochemical properties of different batches of the Scutellaria baicalensis decoction.
Experiment NumbersNumber of Herb MaterialThe Yield of Baicalin (mg/g)
Z1
The Yield of Wogonoside (mg/g)
Z2
The Yield of Baicalein (mg/g)
Z3
The Yield of Total Solids (mg/g)
Z4
Purity of Baicalin (%)
Z5
Purity of Wogonoside (%)
Z6
Purity of Baicalein (%)
Z7
1S199.2921.002.12387.925.595.410.55
2S290.7819.111.97458.719.794.170.43
3S395.7520.801.35441.221.704.710.31
4S199.2921.002.12387.925.595.410.55
5S290.7819.111.97458.719.794.170.43
6S482.7420.171.75491.216.844.110.36
7S570.8117.272.64466.315.183.700.57
8S482.7420.171.75491.216.844.110.36
9S570.8117.272.64466.315.183.700.57
10S693.7820.621.91440.421.294.680.43
11S789.2319.121.28399.422.344.790.32
12S693.7820.621.91440.421.294.680.43
13S789.2319.121.28399.422.344.790.32
14S395.7520.801.35441.221.704.710.31
15S395.7520.801.35441.221.704.710.31
16S886.2121.180.910453.918.994.670.20
17S982.2019.171.59476.717.244.020.33
Table 4. Pearson correlation coefficient and the p value obtained from the correlation analysis of the properties of Scutellaria baicalensis.
Table 4. Pearson correlation coefficient and the p value obtained from the correlation analysis of the properties of Scutellaria baicalensis.
Yield of Baicalin (mg/g)Yield of Wogonoside (mg/g)Yield of Baicalein (mg/g)Yield of Total Solids (mg/g)Purity of Baicalin (%)Purity of Wogonoside (%)
Yield of Wogonoside (mg/g)Z20.808
(0.000)
Yield of Baicalein (mg/g)Z3−0.413
(0.099)
−0.559
(0.020)
Yield of Total Solids (mg/g)Z4−0.630
(0.007)
−0.297
(0.247)
0.138
(0.597)
Purity of Baicalin (%)Z50.914
(0.000)
0.640
(0.006)
−0.292
(0.255)
−0.887
(0.000)
Purity of Wogonoside (%)Z60.866
(0.000)
0.747
(0.001)
−0.366
(0.149)
−0.854
(0.000)
0.960
(0.000)
Purity of Baicalein (%)Z7−0.199
(0.444)
−0.424
(0.090)
0.954
(0.000)
−0.155
(0.552)
−0.012
(0.965)
(p value).
Table 5. Experimental results of DSD.
Table 5. Experimental results of DSD.
Experiment NumberNumber of Herb MaterialsYield of Baicalin (mg/g)
Y1
Yield of Wogonoside (mg/g)
Y2
Yield of Baicalein (mg/g)
Y3
Yield of Total Solids (mg/g)
Y4
1S11.8600.032200.016702.840
2S217.640.25440.166224.87
3S336.040.48430.233449.33
4S117.450.13780.0526021.96
5S216.500.15680.0589021.16
6S45.6300.07390.021308.590
7S529.380.27670.150140.12
8S424.500.37170.0768032.70
9S531.760.31380.104441.46
10S626.660.32210.186135.27
11S76.6400.09810.012209.500
12S630.290.21950.106640.62
13S717.220.16220.0543022.78
14S322.510.31690.121330.39
15S328.810.28770.263637.40
16S824.920.31560.0488032.94
17S920.730.21790.112826.66
Table 6. Analysis of variance results for multiple regression models. Yi is the yield of the i-th component (mg/g), and Xi is the i-th CPP.
Table 6. Analysis of variance results for multiple regression models. Yi is the yield of the i-th component (mg/g), and Xi is the i-th CPP.
TermsY1Y2Y3Y4
Regression CoefficientPRegression CoefficientPRegression CoefficientPRegression CoefficientP
constant150.72-0.6993-5.77-187.96-
Z1 0.0045<0.0001
X1
X2 −0.00390.0044
X3
X4 −0.2558<0.0001−18.140.0665
X5−30.65<0.0001 −2.530.0007−33.57<0.0001
X22 0.000020.0118
X52 −0.00770.05160.27510.0012
X1X3 0.00180.0008
X2X3 0.00020.0005
X4X5 −0.08180.0005
p value<0.0001<0.0001<0.0001<0.0001
R20.82230.84220.95930.8474
R a d j 2 0.81040.80580.92760.8256
Table 7. The lower limit of each critical process evaluation indicator and the probability requirements for meeting the criteria.
Table 7. The lower limit of each critical process evaluation indicator and the probability requirements for meeting the criteria.
Critical Process Evaluation IndicatorsLower LimitsMinimum Probability of Reaching the Criteria
The yield of baicalin (mg/g)13≥80%
The yield of wogonoside (mg/g)0.1
The yield of baicalein (mg/g)0.03
The yield of total solids (mg/g)15
Table 8. Verification of experimental point conditions and results (n = 3).
Table 8. Verification of experimental point conditions and results (n = 3).
Experimental Conditions and Process Evaluation IndicatorsInside Design Space
V1V2V3V4V5V6
Z185.46885.46885.46890.12790.12790.127
X12.22.22.21.31.31.3
X2353535303030
X36.5646.5516.5117.5367.5677.507
X40.80.80.80.90.90.9
X54.1374.1154.0684.1324.1574.257
Y1Predicted values (mg/g)23.9124.5826.0224.0623.2920.23
Measured values (mg/g)34.9737.2538.5725.3119.9726.89
Y2Predicted values (mg/g)0.28710.28910.29310.31520.31270.3029
Measured values (mg/g)0.27820.32050.32250.31830.27100.3717
Y3Predicted values (mg/g)0.04680.05240.06330.14780.13890.1103
Measured values (mg/g)0.13210.21790.11860.08400.07580.1107
Y4Predicted values (mg/g)34.5735.3135.6632.9332.0928.73
Measured values (mg/g)38.6444.8547.6429.6425.6034.16
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, X.; Tang, Z.; Chen, B.; Gong, X. Parameter Optimization Considering the Variations Both from Materials and Process: A Case Study of Scutellaria baicalensis Extract. Separations 2025, 12, 165. https://doi.org/10.3390/separations12060165

AMA Style

Zhang X, Tang Z, Chen B, Gong X. Parameter Optimization Considering the Variations Both from Materials and Process: A Case Study of Scutellaria baicalensis Extract. Separations. 2025; 12(6):165. https://doi.org/10.3390/separations12060165

Chicago/Turabian Style

Zhang, Xuecan, Zhilong Tang, Bo Chen, and Xingchu Gong. 2025. "Parameter Optimization Considering the Variations Both from Materials and Process: A Case Study of Scutellaria baicalensis Extract" Separations 12, no. 6: 165. https://doi.org/10.3390/separations12060165

APA Style

Zhang, X., Tang, Z., Chen, B., & Gong, X. (2025). Parameter Optimization Considering the Variations Both from Materials and Process: A Case Study of Scutellaria baicalensis Extract. Separations, 12(6), 165. https://doi.org/10.3390/separations12060165

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop